Your browser doesn't support javascript.
loading
Targeting of cathepsin S reduces cystic fibrosis-like lung disease.
Small, Donna M; Brown, Ryan R; Doherty, Declan F; Abladey, Anthony; Zhou-Suckow, Zhe; Delaney, Rebecca J; Kerrigan, Lauren; Dougan, Caoifa M; Borensztajn, Keren S; Holsinger, Leslie; Booth, Robert; Scott, Christopher J; López-Campos, Guillermo; Elborn, J Stuart; Mall, Marcus A; Weldon, Sinéad; Taggart, Clifford C.
Afiliação
  • Small DM; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Brown RR; These two authors contributed equally to this work.
  • Doherty DF; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Abladey A; These two authors contributed equally to this work.
  • Zhou-Suckow Z; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Delaney RJ; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Kerrigan L; Dept of Translational Pulmonology, Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), University of Heidelberg, Heidelberg, Germany.
  • Dougan CM; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Borensztajn KS; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Holsinger L; Airway Innate Immunity Research (AiiR) Group, Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Booth R; INSERM UMRS_933, Université Pierre et Marie Curie, Hôpital Trousseau, Paris, France.
  • Scott CJ; ViroBay Inc., Menlo Park, CA, USA.
  • López-Campos G; ViroBay Inc., Menlo Park, CA, USA.
  • Elborn JS; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Mall MA; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Weldon S; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Taggart CC; Respiratory Medicine, Imperial College and Royal Brompton Hospital, London, UK.
Eur Respir J ; 53(3)2019 03.
Article em En | MEDLINE | ID: mdl-30655278
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Catepsinas / Fibrose Cística / Receptor PAR-2 / Muco Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Catepsinas / Fibrose Cística / Receptor PAR-2 / Muco Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Revista: Eur Respir J Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido